In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable is joined by Dr. Doug Thamm, Stuart Presidential Chair in Oncology and Director of Clinical Research at the Colorado State University Flint Animal Cancer Center. Dr. Thamm discusses how naturally occurring cancers in dogs are advancing cancer drug development and informing treatment strategies in both veterinary and human medicine. He shares real-world examples of comparative oncology in action and the role clinical trials play in bringing new therapies to patients. The conversation also explores the challenges of oncology drug development, regulatory pathways, and emerging areas such as biologics, genomic sequencing, and AI-driven tools—offering a clear-eyed view of where veterinary oncology is headed.

📝Transcripts are available at https://www.imprimedicine.com/podcast.

To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp

Music Credit: Hazy by Beat Mekanik

In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Joseph Impellizeri, a true trailblazer in targeted electrochemotherapy and gene electrotransfer immunotherapy. Dr. Impellizeri shares how electroporation-based treatments are transforming cancer care by allowing localized delivery of chemotherapy and immunotherapy with minimal side effects. He discusses how this technology has evolved from treating skin tumors to tackling complex cases like oral, nasal, and even bone cancers — and how it can complement traditional modalities such as surgery, chemotherapy, and radiation. The conversation also explores his groundbreaking work combining gene electrotransfer with PD-1 inhibitors, offering a glimpse into the future of veterinary oncology and more compassionate, targeted treatment options for patients.

📝Transcripts are available at https://www.imprimedicine.com/podcast.

To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp

Music Credit: Hazy by Beat Mekanik

In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Chad Johannes, Associate Professor and Executive Director of the Veterinary Teaching Hospital at Colorado State University and former medical director at Aratana Therapeutics, who also helped launch Palladia at Pfizer Animal Health (Now Zoetis). Dr. Johannes reflects on his path across private practice, industry, and academia — sharing practical lessons on burnout, career pivots, and the value of mentorship and flexibility in professional growth. The conversation explores how immunotherapy and AI are advancing precision oncology and how empowering general practitioners with options like CCNU, Laverdia, and Palladia can expand access to care. Tune in for a candid look at the economics and innovations shaping the next chapter of veterinary oncology.

📝Transcripts are available at https://www.imprimedicine.com/podcast.

To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp

Music Credit: Hazy by Beat Mekanik